US Treasury Settlement Offers Legal Relief to Gautam Adani Amid Sanctions Case Standard Chartered to Reduce Thousands of Roles Amid AI Integration Plans Redeployment Markets Raise Chances for a Fed Rate Hike Following Hot Inflation Report Angi ANGI Stock Up 092 Key Resistance at 520 20260514 A SPAC III ASPC Q1 2026 Financial Overview Spotify Surges 15 on Landmark AI Music Deal with UMG and Updated Guidance TotalEnergies SE TTE Q1 2026 Crushes Forecasts EPS 245 vs 229 ABVC BioPharma Inc ABVC Holds Steady Above Support After Modest Gain Economy and Welfare Alan Milburn Criticizes Imbalance in Youth Spending Calls for Reform Too Much Cash 27YearOld With 70K in Savings Seeks Advice on Deployment US Races to Establish Ebola Quarantine Facility in Kenya Implications for Global Health Security and Markets Taiwan Chip Stocks Surge After Nvidias 150 Billion Spending Commitment Jim Cramer Investigates Adobe ADBE What It Means for Investors Dating Startups Innovate to Combat Fake Profiles Potentially Reshaping Online Dating Industry Rexford Industrial Realty Q1 2026 Earnings Strong EPS Beat Amid Stable Operations ETON Q1 2026 Earnings EPS Misses Estimates Revenue Details Not Disclosed Energy Focus Inc EFOI Q4 2024 Earnings Loss Per Share Narrows as Stock Rebounds NovaBridge Biosciences NBP Q4 2025 Earnings Staggering EPS Miss as PreRevenue Biotech Faces Development Headwinds T Stamp IDAI Q1 2026 Earnings EPS Miss Weighs on Sentiment as Stock Edges Higher CCB Q1 2026 Earnings EPS Misses Estimates by 261 Amid Challenging Environment CART Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction CSL Q1 2026 Earnings EPS Surpasses Estimates by 78 Stock Rises Modestly KNSL Q1 2026 Earnings EPS Surprises 672 to the Upside Stock Slips PRIM Q1 2026 Earnings EPS Misses Estimates by 315 Amid Operational Headwinds InspireMD Inc NSPR Q1 2026 Earnings Narrower Loss Than Expected But Shares Slide Life360 Reports Record Q1 2026 Results Driven by Subscription and Advertising Growth QURE Q1 2026 Earnings NarrowerthanExpected Loss as Gene Therapy Developer Continues Pipeline Progress